Cargando…

COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India

PURPOSE: To understand the benefits of COVID-19 vaccination (Covishield, Covaxin) on clinical features and outcome of COVID-19 during the third wave in India. MATERIALS AND METHODS: The primary study aim was to describe the clinical profile and outcome of COVID-19 regarding their vaccination and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Atul K., Patel, Dhruv, Shevkani, Manoj, Shah, Aniket, Madan, Surabhi, Gohel, Swati, Chhatwani, Chirag, Doshi, Aakash, Patel, Vipul, Sukhwani, Kalpesh, Kareliya, Hiten, Shah, Vipul, Savaj, Pratik, Rana, Manish, Patel, Ketan K., Bakshi, Harsh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Association of Medical Microbiologists. Published by Elsevier B.V. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793696/
https://www.ncbi.nlm.nih.gov/pubmed/36870745
http://dx.doi.org/10.1016/j.ijmmb.2022.12.004
_version_ 1784859889642766336
author Patel, Atul K.
Patel, Dhruv
Shevkani, Manoj
Shah, Aniket
Madan, Surabhi
Gohel, Swati
Chhatwani, Chirag
Doshi, Aakash
Patel, Vipul
Sukhwani, Kalpesh
Kareliya, Hiten
Shah, Vipul
Savaj, Pratik
Rana, Manish
Patel, Ketan K.
Bakshi, Harsh
author_facet Patel, Atul K.
Patel, Dhruv
Shevkani, Manoj
Shah, Aniket
Madan, Surabhi
Gohel, Swati
Chhatwani, Chirag
Doshi, Aakash
Patel, Vipul
Sukhwani, Kalpesh
Kareliya, Hiten
Shah, Vipul
Savaj, Pratik
Rana, Manish
Patel, Ketan K.
Bakshi, Harsh
author_sort Patel, Atul K.
collection PubMed
description PURPOSE: To understand the benefits of COVID-19 vaccination (Covishield, Covaxin) on clinical features and outcome of COVID-19 during the third wave in India. MATERIALS AND METHODS: The primary study aim was to describe the clinical profile and outcome of COVID-19 regarding their vaccination and to identify risk factors for disease progression in vaccinated patients. This was a prospective observational multicentric study of COVID-19 attended by Infectious Disease physicians during January 15, 2022 to February 15, 2022. Adult patients with positive RT-PCR or rapid antigen test for COVID-19 were enrolled. Patient received treatment as per local institutional protocol. Chi square test for categorical and Mann Whitney test for continuous variables were applied for the analysis. Logistic regression was used to calculate adjusted odds ratios. RESULTS: A total of 788 patients were included in analysis out of 883 enrolled patients from 13 centers across Gujarat. By the end of two weeks’ follow up, 22 patients (2.8%) had expired. The Median age of subjects was 54 years, with a (55.8%) male. 90% of the subjects were vaccinated, majority (77%) of them had received 2 doses of vaccine with Covishield (659, 93%). Mortality among the non-vaccinated was significantly (11.4%) higher than vaccinated (1.8%). Logistic regression analysis showed numbers of comorbidities (p ​= ​0.027), baseline higher WBC count (p ​= ​0.02), higher NLR (p ​= ​0.016), and Ct value (p ​= ​0.046) were associated with mortality while vaccination was associated with survival (p ​= ​0.001). The factors associated with mortality among vaccinated were age, comorbidities, baseline higher WBC, NLR, and CRP. CONCLUSIONS: Omicron variant was associated with mild symptoms. Clinical and laboratory risk factors for getting severe disease with Omicron variant were the same with previous SARS CoV-2 strain. Two doses of vaccine protect people against severe disease and death. Age, comorbidities, baseline leucocytosis, high NLR, elevated CRP are the risk factors for poor outcome in vaccinated patients.
format Online
Article
Text
id pubmed-9793696
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Indian Association of Medical Microbiologists. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-97936962022-12-27 COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India Patel, Atul K. Patel, Dhruv Shevkani, Manoj Shah, Aniket Madan, Surabhi Gohel, Swati Chhatwani, Chirag Doshi, Aakash Patel, Vipul Sukhwani, Kalpesh Kareliya, Hiten Shah, Vipul Savaj, Pratik Rana, Manish Patel, Ketan K. Bakshi, Harsh Indian J Med Microbiol Original Research Article PURPOSE: To understand the benefits of COVID-19 vaccination (Covishield, Covaxin) on clinical features and outcome of COVID-19 during the third wave in India. MATERIALS AND METHODS: The primary study aim was to describe the clinical profile and outcome of COVID-19 regarding their vaccination and to identify risk factors for disease progression in vaccinated patients. This was a prospective observational multicentric study of COVID-19 attended by Infectious Disease physicians during January 15, 2022 to February 15, 2022. Adult patients with positive RT-PCR or rapid antigen test for COVID-19 were enrolled. Patient received treatment as per local institutional protocol. Chi square test for categorical and Mann Whitney test for continuous variables were applied for the analysis. Logistic regression was used to calculate adjusted odds ratios. RESULTS: A total of 788 patients were included in analysis out of 883 enrolled patients from 13 centers across Gujarat. By the end of two weeks’ follow up, 22 patients (2.8%) had expired. The Median age of subjects was 54 years, with a (55.8%) male. 90% of the subjects were vaccinated, majority (77%) of them had received 2 doses of vaccine with Covishield (659, 93%). Mortality among the non-vaccinated was significantly (11.4%) higher than vaccinated (1.8%). Logistic regression analysis showed numbers of comorbidities (p ​= ​0.027), baseline higher WBC count (p ​= ​0.02), higher NLR (p ​= ​0.016), and Ct value (p ​= ​0.046) were associated with mortality while vaccination was associated with survival (p ​= ​0.001). The factors associated with mortality among vaccinated were age, comorbidities, baseline higher WBC, NLR, and CRP. CONCLUSIONS: Omicron variant was associated with mild symptoms. Clinical and laboratory risk factors for getting severe disease with Omicron variant were the same with previous SARS CoV-2 strain. Two doses of vaccine protect people against severe disease and death. Age, comorbidities, baseline leucocytosis, high NLR, elevated CRP are the risk factors for poor outcome in vaccinated patients. Indian Association of Medical Microbiologists. Published by Elsevier B.V. 2023 2022-12-27 /pmc/articles/PMC9793696/ /pubmed/36870745 http://dx.doi.org/10.1016/j.ijmmb.2022.12.004 Text en © 2022 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Research Article
Patel, Atul K.
Patel, Dhruv
Shevkani, Manoj
Shah, Aniket
Madan, Surabhi
Gohel, Swati
Chhatwani, Chirag
Doshi, Aakash
Patel, Vipul
Sukhwani, Kalpesh
Kareliya, Hiten
Shah, Vipul
Savaj, Pratik
Rana, Manish
Patel, Ketan K.
Bakshi, Harsh
COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India
title COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India
title_full COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India
title_fullStr COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India
title_full_unstemmed COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India
title_short COVID-19 patients’ clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India
title_sort covid-19 patients’ clinical profile and outcome with respect to their vaccination status: a prospective observational multicentre cohort study during third wave in western india
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793696/
https://www.ncbi.nlm.nih.gov/pubmed/36870745
http://dx.doi.org/10.1016/j.ijmmb.2022.12.004
work_keys_str_mv AT patelatulk covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT pateldhruv covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT shevkanimanoj covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT shahaniket covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT madansurabhi covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT gohelswati covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT chhatwanichirag covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT doshiaakash covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT patelvipul covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT sukhwanikalpesh covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT kareliyahiten covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT shahvipul covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT savajpratik covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT ranamanish covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT patelketank covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia
AT bakshiharsh covid19patientsclinicalprofileandoutcomewithrespecttotheirvaccinationstatusaprospectiveobservationalmulticentrecohortstudyduringthirdwaveinwesternindia